Mononitron Ep (Isosorbide Mononitrate)

Isosorbide Mononitrate, the active ingredient in Mononitron Ep, is a nitrate vasodilator presented as an oral tablet for oral use. It is employed to prevent and treat angina pectoris in adults, helping to reduce the frequency of chest pain episodes by improving myocardial oxygen supply. It is indicated for patients with chronic stable angina and is taken once daily as prescribed.

GNH USA supplies Mononitron Ep as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Isosorbide Mononitrate acts on the nitrate pathway to relieve angina symptoms.

- Prophylaxis of angina pectoris: reduces the frequency of angina attacks in patients with known coronary artery disease. - Treatment of chronic stable angina: improves exercise tolerance and decreases chest pain episodes during daily activities. - Ischemic heart disease: provides symptomatic relief by enhancing myocardial oxygen delivery.

Common Side Effects: - Headache: mild to moderate throbbing pain, often transient. - Dizziness or light‑headedness: related to blood pressure reduction. - Flushing: warm sensation and reddening of the skin. - Nausea or abdominal discomfort: gastrointestinal upset. - Palpitations: awareness of heartbeat, usually benign.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Syncope: sudden loss of consciousness due to low blood pressure. - Myocardial infarction (rare): chest pain persisting despite therapy. - Life‑threatening allergic reaction: rash, swelling, or difficulty breathing. - Methemoglobinemia: rare disorder causing reduced oxygen delivery.

Before initiating therapy, consider the following precautions.

- Dose adjustment: evaluate renal or hepatic impairment and adjust dose accordingly. - Severe hypotension: avoid use in patients with markedly low blood pressure. - Concomitant PDE‑5 inhibitors: do not combine with sildenafil, tadalafil, or similar agents. - Monitor for cyanosis or methemoglobinemia, especially in patients with pre‑existing blood disorders. - Store at room temperature: keep in the original pack, protect from moisture and light.

Isosorbide Mononitrate may interact with several drug classes.

Major Interactions (Avoid): - Other nitrates (e.g., nitroglycerin): additive vasodilation can cause dangerous hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): risk of severe blood pressure fall.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may enhance blood‑pressure‑lowering effect. - Diuretics: can increase risk of orthostatic hypotension. - Alcohol: may potentiate vasodilatory side effects such as dizziness and flushing.